# Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis

> **NCT00583531** · PHASE2 · TERMINATED · sponsor: **Ocera Therapeutics** · enrollment: 2 (actual)

## Conditions studied

- Pouchitis

## Interventions

- **DRUG:** AST-120

## Key facts

- **NCT ID:** NCT00583531
- **Lead sponsor:** Ocera Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2014-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00583531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00583531, "Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00583531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*